47 related articles for article (PubMed ID: 494338)
1. Remarks about fractionation schemes.
Wideröe R
Strahlentherapie; 1979 Oct; 155(10):666-72. PubMed ID: 494338
[TBL] [Abstract][Full Text] [Related]
2. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
3. Arrhenius relationships from the molecule and cell to the clinic.
Dewey WC
Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
[TBL] [Abstract][Full Text] [Related]
4. [Electron therapy].
Wideröe R
Strahlentherapie; 1977 Mar; 153(3):133-42. PubMed ID: 402715
[TBL] [Abstract][Full Text] [Related]
5. [Biomedical use and dosimetry of pions of the sin 590 MeV isochrone cyclotrone. VII. Radiation therapy using negative pions (author's transl)].
Wideröe R
Rofo; 1976 Feb; 124(2):182-5. PubMed ID: 131072
[TBL] [Abstract][Full Text] [Related]
6. An historical survey of radiobiology and radiotherapy with fast neutrons.
Field SB
Curr Top Radiat Res Q; 1976 Jan; 11(1):1-86. PubMed ID: 1106959
[TBL] [Abstract][Full Text] [Related]
7. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
[TBL] [Abstract][Full Text] [Related]
8. The relative significance of repopulation and hypoxic clonogens in the fractionated radiotherapy of a mouse tumor.
Urano M; Nishimura Y; Yaes R
Radiat Res; 1995 May; 142(2):204-11. PubMed ID: 7724736
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of time dose distribution in radiotherapy].
Schulz U; Bamberg M; Notter G; Scherer E
Strahlentherapie; 1982 Nov; 158(11):639-45. PubMed ID: 7157424
[TBL] [Abstract][Full Text] [Related]
10. Improved tolerance with two radiation fractions per day for treatment of abdominal and pelvic malignancies.
Loeffler RK
Am J Clin Oncol; 1983 Dec; 6(6):619-27. PubMed ID: 6416050
[TBL] [Abstract][Full Text] [Related]
11. [Calculation of the dose distribution with time in the planning of radiation treatment].
Zevrieva IF
Med Radiol (Mosk); 1983 Apr; 28(4):58-62. PubMed ID: 6835074
[TBL] [Abstract][Full Text] [Related]
12. Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients.
Siegel JA; Yeldell D; Goldenberg DM; Stabin MG; Sparks RB; Sharkey RM; Brenner A; Blumenthal RD
J Nucl Med; 2003 Jan; 44(1):67-76. PubMed ID: 12515878
[TBL] [Abstract][Full Text] [Related]
13. [Late progressive radiation myelopathies. A study of 27 cases].
Combes PF; Daly N; Schlienger M; Humeau F
J Radiol Electrol Med Nucl; 1975 Nov; 56(11):815-25. PubMed ID: 815547
[TBL] [Abstract][Full Text] [Related]
14. [Dose-time optimization in fractionated radiotherapy].
Kriester A; Kloetzer KH; Kob D
Strahlenther Onkol; 1988 Aug; 164(8):489-98. PubMed ID: 3138769
[TBL] [Abstract][Full Text] [Related]
15. Nominal standard dose and tumor standard dose. Tables for radiation therapy planning and analysis.
Kuisk H; Khan FM
Acta Radiol Ther Phys Biol; 1975; (345 suppl):1-151. PubMed ID: 1234821
[TBL] [Abstract][Full Text] [Related]
16. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
18. [Role of radiotherapy in combined therapy of soft tissue sarcoma in children and adolescents].
Golubicić I; Nikitović M; Bokun J; Gavrilović D; Radosević-Jelić Lj
Srp Arh Celok Lek; 2000; 128(5-6):172-8. PubMed ID: 11089417
[TBL] [Abstract][Full Text] [Related]
19. Cellular survival and isoeffect formulae: a study in applied radiobiology.
Wideröe R
Rofo; 1975 Nov; 123(5):475-81. PubMed ID: 128509
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of radiation treatment effectiveness using the rated standard dose (RSD) under different irradiation conditions].
Minenko VF
Med Radiol (Mosk); 1983 Mar; 28(3):57-9. PubMed ID: 6835060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
